Date: 2025-10-08Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision (EU) 2025/1650 of the European Parliament of 7 May 2025 on the closure of the accounts of the European Monitoring Centre for Drugs and Drug Addiction (now European Union Drugs Agency) for the financial year 2023
**Executive Summary**
This is a Decision (EU) 2025/1650 of the European Parliament, dated 7 May 2025, concerning the closure of the accounts of the European Monitoring Centre for Drugs and Drug Addiction (now European Union Drugs Agency) for the financial year 2023. The decision was published in the Official Journal on 8 October 2025. The document approves the closure of the accounts and instructs the President to forward the decision for publication and to various entities.
**Key Points / Main Content**
* **Approval of Account Closure:**
* The European Parliament approves the closure of the accounts of the European Monitoring Centre for Drugs and Drug Addiction (now European Union Drugs Agency) for the financial year 2023.
* **Instruction to the President:**
* The President of the European Parliament is instructed to forward the decision to the following entities:
* The Director of the European Union Drugs Agency
* The Council
* The Commission
* The Court of Auditors
* The President is also instructed to arrange for the publication of the decision in the Official Journal of the European Union (L series).
**Impact Analysis**
**European Monitoring Centre for Drugs and Drug Addiction / European Union Drugs Agency**
* **Impact** The agency's accounts for the financial year 2023 are formally closed.
* **Action Required:** The Director of the agency receives notification of the account closure.
**Council**
* **Impact:** The Council receives notification of the account closure decision.
* **Action Required:** No specific action outlined.
**Commission**
* **Impact:** The Commission receives notification of the account closure decision.
* **Action Required:** No specific action outlined.
**Court of Auditors**
* **Impact:** The Court of Auditors receives notification of the account closure decision.
* **Action Required:** No specific action outlined.
**European Parliament President**
* **Impact:** The President of the European Parliament is officially instructed to forward the decision and arrange for publication.
* **Action Required:** The President must ensure the decision is forwarded to the specified entities and published in the Official Journal.
Key Entities Referenced
European Monitoring Centre for Drugs and Drug Addiction: Agency whose accounts for the financial year 2023 are being closed, later renamed the European Union Drugs Agency.
European Union Drugs Agency: The successor to the European Monitoring Centre for Drugs and Drug Addiction.
Regulation (EU, Euratom) 2018/1046: Regulation on the financial rules applicable to the general budget of the Union.
Regulation (EU) 2023/1322: Regulation establishing the European Union Drugs Agency (EUDA) and repealing Regulation (EC) No 1920/2006.
European Parliament: EU body issuing the decision on the closure of the accounts.
Official Journal EN
of the European Union L series
2025/1650 8.10.2025
DECISION(EU) 2025/1650 OF THE EUROPEAN PARLIAMENT
of 7 May 2025
on the closure of the accounts of the European Monitoring Centre for Drugs and Drug Addiction
(now European Union Drugs Agency) for the financial year 2023
THE EUROPEAN PARLIAMENT,
— having regard to the final annual accounts of the European Monitoring Centre for Drugs and Drug Addiction for the
financial year 2023,
— having regard to the Court of Auditors’ annual report on EU agencies for the financial year 2023, together with the
agencies’ replies(1),
— having regard to the statement of assurance(2)as to the reliability of the accounts and the legality and regularity of the
underlying transactions provided by the Court of Auditors for the financial year 2023, pursuant to Article 287 of the
Treaty on the Functioning of the European Union,
— having regard to the Council’s recommendation of 17 February 2025 on discharge to be given to the Centre in
respect of the implementation of the budget for the financial year 2023 (05755/2025 – C10-0024/2025),
— having regard to Article 319 of the Treaty on the Functioning of the European Union,
— having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July
2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU)
No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU)
No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation
(EU, Euratom) No 966/2012(3), and in particular Article 70 thereof,
— having regard to Regulation (EU, Euratom) 2024/2509 of the European Parliament and of the Council of
23 September 2024 on the financial rules applicable to the general budget of the Union(4), and in particular
Article 70 thereof,
— having regard to Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December
2006 on the European Monitoring Centre for Drugs and Drug Addiction(5), and in particular Article 15 thereof,
— having regard to Regulation (EU) 2023/1322 of the European Parliament and of the Council of 27 June 2023 on the
European Union Drugs Agency (EUDA) and repealing Regulation (EC) No 1920/2006(6), and in particular Article 41
thereof,
— having regard to Commission Delegated Regulation (EU) 2019/715 of 18 December 2018 on the framework
financial regulation for the bodies set up under the TFEU and Euratom Treaty and referred to in Article 70 of
Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council(7), and in particular
Article 105 thereof,
— having regard to Rule 102 of and Annex V to its Rules of Procedure,
— having regard to the opinions of the Committee on Employment and Social Affairs, the Committee on the
Environment, Climate and Food Safety, the Committee on Transport and Tourism, the Committee on Fisheries, the
Committee on Culture and Education, the Committee on Civil Liberties, Justice and Home Affairs, and the
Committee on Women's Rights and Gender Equality,
— having regard to the report of the Committee on Budgetary Control (A10-0065/2025),
(1) OJ C, C/2024/6332, 24.10.2024, ELI: http://data.europa.eu/eli/C/2024/6332/oj.
(2) OJ C, C/2024/6041, 10.10.2024, ELI: http://data.europa.eu/eli/C/2024/6041/oj.
(3) OJ L 193, 30.7.2018, p. 1, ELI: http://data.europa.eu/eli/reg/2018/1046/oj.
(4) OJ L, 2024/2509, 26.9.2024, ELI: http://data.europa.eu/eli/reg/2024/2509/oj.
(5) OJ L 376, 27.12.2006, p. 1, ELI: http://data.europa.eu/eli/reg/2006/1920/oj.
(6) OJ L 166, 30.6.2023, p. 6, ELI: http://data.europa.eu/eli/reg/2023/1322/oj.
(7) OJ L 122, 10.5.2019, p. 1, ELI: http://data.europa.eu/eli/reg_del/2019/715/oj.
ELI: http://data.europa.eu/eli/dec/2025/1650/oj 1/2EN
OJ L, 8.10.2025
1. Approves the closure of the accounts of the European Monitoring Centre for Drugs and Drug Addiction for the
financial year 2023;
2. Instructs its President to forward this decision to the Director of European Union Drugs Agency, the Council, the
Commission and the Court of Auditors, and to arrange for its publication in the Official Journal of the European Union
(L series).
The President The Secretary-General
Roberta METSOLA Alessandro CHIOCCHETTI
2/2 ELI: http://data.europa.eu/eli/dec/2025/1650/oj